Abstract
Four patients (six eyes) underwent successful corneal transplantations while receiving systemic cyclosporin. The six eyes had marked corneal vascularization preoperatively and in four, previous grafts had rejected. These eyes were therefore at high risk with respect to the likelihood of rejection and subsequent graft failure. All six grafts have remained clear (mean follow up twelve months) and only one minor rejection episode has occurred: this was easily reversed. The patients were monitored by repeated serum creatinine and trough serum cyclosporin levels. No significant side effects were encountered.
Similar content being viewed by others
References
Batchelor JR, Casey TA, Gibbs DS, Lloyd DF, Werb A, Prasad SS and James A (1976) HLA matching and corneal grafting. Lancet 1:551–554
Bell TAG, Easty DL and McCullagh KG (1982) A placebo controlled blind trial of Cyclosporin A in prevention of corneal graft rejection in rabbits. Brit J Ophthal. 66: 303–308
Brown SI, Bloomfield SE and Pearce DB (1974) A follow up on transplantation of the alkali burned cornea. Amer J Ophthal 77:538–542
Casey TA and Mayer DJ (1984) Corneal grafting; principles and practice. Philadelphia, Saunders, pp. 309–324
Coster DJ, Shepherd WFI, Chin Fook T, Rice NSC and Jones BR (1979) Prolonged survival of corneal allografts in rabbits treated with Cyclosporin A. Lancet 2:655–689
Donatsch P, Abisch E, Hornberger M, Traber R, Trapp M, and Voges R (1981) A radioimmune assay to measure Cyclosporin A in plasma and serum samples. J Immunoassay 2:19–22
Editorial (1983) Cyclosporin and Neoplasia. Lancet 1:1083
Foulks GN and Sanfilippo F (1982) Beneficial effects of histocompatibility in high risk corneal transplantation. Amer J Ophthal 94:622–629
Gibbs DD, Bachelor JR, Werb A, Schlesinger W and Casey TA (1974) The influence of tissue type compatibility on the fate of full thickness corneal grafts. Trans Ophthal Soc UK 94: 101–126
Hows JM, Chipping PM, Fairhead S, Smith J, Bangham A and Gordon-Smith EC (1983) Nephrotoxicity in bone marrow transplant recipients treated with Cyclosporin A. Brit J Haemat. 54:69–78
Khodadoust AA (1973) The allograft rejection reaction. The leading cause of late failure of clinical corneal grafts in: Corneal graft failure. Ciba Foundation Symposium (new series) 15:151–167
Khodadoust AA and Abizadeh A (1979) The fate of corneal regrafts after previous rejection reaction. In: Silverstein AM and O'Connor GR (eds): Immunology and Immunopathy of the Eye. New York, Masson pp 167–173
Maumenee AE (1951) The influence of donor recipient sensitization on corneal grafts. Amer J Ophthal. 34:142–152
McCarey BE and Kaufman HE (1974) Improved corneal storage. Invest Ophthal 13: 165–173
Morris PJ (1981) Cyclosporin A. Transplantation 32:349–354
Nussenblatt RB, Rook AH, Wacker WB, Palestine AG, Scher I and Gery I (1983) Treatment of intraocular inflammatory disease with Cyclosporin A. Lancet 2:235–238
Shepherd WFI, Coster DJ, Chin Fook T, Rice NSC and Jones BR (1980) Effect of Cyclosporin A on the survival of corneal grafts in rabbits. Brit J Ophthal 64:148–153
Weetman AP, Ludgate M, Mills PV, McGregor AM, Beck L, Lazarus JH and Hall R (1983) Cyclosporin improves Graves' Ophthalmology. Lancet 2:486–489
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hill, J.C. The use of systemic cyclosporin a in human corneal transplantation: a preliminary report. Doc Ophthalmol 62, 337–344 (1986). https://doi.org/10.1007/BF00168265
Issue Date:
DOI: https://doi.org/10.1007/BF00168265